Research

Solving Kids' Cancer (US and UK) together with the Max Cure Foundation hosted a webinar on the impact of the current pandemic on the paediatric oncology research landscape. Read more

Latest

Nellie-Rose's Campaign

Nellie-Rose is battling a disease no child should have to. She has high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.

I’ve had the pleasure of looking after Henry when he was nursery. He is the most loveable little boys you’ll ever met. His hugs are the best and his love for fireman Sam is what we would spend hours talking about 💙

Henry needs your help please help us

Ellie’s reading challenge to help Liam

Ellie wanted to help Liam as he is running out of time and his family are so close in getting Liam a life saving vaccine.
Ellie has challenge herself to read 8 books a day to support Liams appeal 💙

Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

Lily-Mae from Galway, Ireland will be celebrating her 12th birthday this April, but for her parents Judith and Leighton every day is a blessing.

Corey is thriving after neuroblastoma battle

Family donate almost £150,000 to neuroblastoma research

Liam's Appeal

Liam has high-risk neuroblastoma and his family are appealing for your help to raise £232,000 by August 2020.

BEACON study opens in Europe

The much-anticipated BEACON study amendment is now open and recruiting patients.

Steve Richards to step down as Chief Executive

CEO to leave Solving Kids' Cancer after three years in the role.

Nellie-Rose's Campaign

Nellie-Rose is battling a disease no child should have to. She has high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.

Solving Kids’ Cancer appoints new Chief Executive Officer

Solving Kids’ Cancer, a national neuroblastoma charity, has appointed Gail Jackson as its new Chief Executive Officer.

Charities fund new clinical trial

Solving Kids’ Cancer, with Neuroblastoma UK, has awarded a grant of £609,762.40 to enable the SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) to open in the UK, it is anticipated to open in early 2021.

Ewen's Urgent Appeal

Ewen is a happy and restless boy who runs everywhere. He loves trucks, cars and blowing dandelions. But this amazing little boy has had his childhood interrupted by childhood cancer.

Maya’s Appeal

Maya is accessing the Bivalent Vaccine in New York but still desperately needs your help to raise the funds to finish it.

Research

SIOPE Meeting, Prague, May 2019

Research Update - May 2020

Covid-19 - The Impact on our research landscape webinar